An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)
Clinical trial NCT00796120 · COMPLETED
Trial details
- NCT number
- NCT00796120
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2012-08-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.